Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2020
Support of a molecular tumour board by an evidence-based decision management system for precision oncology
Mario Lamping, Manuela Benary, Serge Leyvraz, et al.
Genome Medicine
|
March 1, 2022
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
Tincy Simon, Pamela Riemer, Armin Jarosch, et al.
The EMBO Journal
|
August 31, 2016
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors
Pia Riemke, Melinda Czeh, Josephine Fischer, et al.
Haematologica
|
November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Sietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Blood
|
August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
German Ott, Marita Ziepert, Wolfram Klapper, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 15, 2013
Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing
Maximilian V Laffert, Arne Warth, Roland Penzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Annette M Staiger, Marita Ziepert, Heike Horn, et al.
Nature Medicine
|
May 4, 2010
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma
Björn Lamprecht, Korden Walter, Stephan Kreher, et al.
Nature
|
August 16, 2013
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
Jan R Dörr, Yong Yu, Maja Milanovic, et al.
Nature
|
December 21, 2017
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic, Dorothy N Y Fan, Dimitri Belenki, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2020
Support of a molecular tumour board by an evidence-based decision management system for precision oncology
Mario Lamping, Manuela Benary, Serge Leyvraz, et al.
Genome Medicine
|
March 1, 2022
DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
Tincy Simon, Pamela Riemer, Armin Jarosch, et al.
The EMBO Journal
|
August 31, 2016
Myeloid leukemia with transdifferentiation plasticity developing from T-cell progenitors
Pia Riemke, Melinda Czeh, Josephine Fischer, et al.
Haematologica
|
November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Sietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Blood
|
August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
German Ott, Marita Ziepert, Wolfram Klapper, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 15, 2013
Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing
Maximilian V Laffert, Arne Warth, Roland Penzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Annette M Staiger, Marita Ziepert, Heike Horn, et al.
Nature Medicine
|
May 4, 2010
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma
Björn Lamprecht, Korden Walter, Stephan Kreher, et al.
Nature
|
August 16, 2013
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
Jan R Dörr, Yong Yu, Maja Milanovic, et al.
Nature
|
December 21, 2017
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic, Dorothy N Y Fan, Dimitri Belenki, et al.
Page
of 8